verified SJR 0,597 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Mary Ann Liebert Inc.

workspace_premium Q2 — Pharmacology lock Subscription

Journal of Ocular Pharmacology and Therapeutics

Journal of Ocular Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Ophthalmology with an H index of 76. It has an SJR impact factor of 0,597 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,597.

ISSN: 1080-7683

Publisher: Mary Ann Liebert Inc.

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,597 Q2

H-index 76

Acceptance rate pie_chart

28% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,597

H-index

Docs (year)

Docs 3y

246

Total refs

3840

Cites 3y

482

Citable 3y

225

Cites/Doc 2y

2.25

Ref/Doc

42.2

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bovine Eye 1-Cys Peroxiredoxin: Expression in E. coli and Antioxidant Properties

Vitrectomy with Fluconazole Infusion: Retinal Toxicity, Pharmacokinetics, and Efficacy in the Treatment of Experimental Candidal Endophthalmitis

Differential Effects of a-Adrenoceptor Agonists on Human Retinal Microvessel Diameter

Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa

Determination of Aldose Reductase Activity in the Eye by Localized Magnetic Resonance Spectroscopy

Curcumin Inhibits Neuronal Loss in the Retina and Elevates Ca2+/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Rats

Corneal and Scleral Permeability of Quinolones - A Pharmacokinetics Study

Comparison of the Effects of Brimonidine 0.2% and Timolol 0.5% on Retinal Nerve Fiber Layer Thickness in Ocular Hypertensive Patients: A Prospective, Unmasked Study

Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration

Comparison of an Immortalized Human Corneal Epithelial Cell Line and Rabbit Corneal Epithelial Cell Culture in Cytotoxicity Testing

Changes in Orbital Hemodynamics Induced by Nipradilol in Healthy Volunteers

Calpain-Induced Light Scattering in Young Rat Lenses is Enhanced by UV-B

SHOW MORE ARTICLES

Brain-Derived Neurotrophic Factor Inhibits Changes in Soma-Size of Retinal Ganglion Cells Following Optic Nerve Axotomy in Rats

3a,5beta-Tetrahydrocortisol Effect on Outflow Facility

Bioavailability in the Human Eye of a Fixed Combination of Latanoprost and Timolol Compared to Monotherapy

Assessment of the Intraocular Pressure-Lowering Activity of Bicyclic Derivatives of 1-Substituted Benzyloctahydroisoquinoline

Assessment of Systemic Adverse Reactions Induced by Ophthalmic beta-Adrenergic Receptor Antagonists

Antioxidant Enzymes in Human Tears

Anti-Inflammatory Effects of Lipoxins on Lipopolysaccharide-Induced Uveitis in Rats

Anti-Excitotoxic Activity of Trimetazidine in the Retina

Amylin Competes for Binding Sites of CGRP in the Chamber Angle and Uvea of Monkey, Cat, and Pig Eye

Alginic Acid Effect on Carteolol Ocular Pharmacokinetics in the Pigmented Rabbit

A Comparison of the Efficacy and Tolerability of 0.5% Timolol Maleate Ophthalmic Gel-Forming Solution QD and 0.5% Levobunolol Hydrochloride BID in Patients with Ocular Hypertension or Open-Angle Glaucoma

A Comparative Study of Effects of Antiproliferative Drugs on Human Retinal Pigment Epithelial Cells in Vitro

FAQs

Journal of Ocular Pharmacology and Therapeutics has an SJR of 0,597 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Ocular Pharmacology and Therapeutics is 28%.

Journal of Ocular Pharmacology and Therapeutics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Ocular Pharmacology and Therapeutics?

What is the APC / publication cost?

What is the acceptance rate?